Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,330.16 +5,199.89 (+8.79%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Annovis Bio, Inc. (ANVS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.45 |
| Open | 5.47 |
| Bid | 5.19 x 1300 |
| Ask | 5.29 x 800 |
| Day's range | 4.86 - 5.73 |
| 52-week range | 4.86 - 22.49 |
| Volume | |
| Avg. volume | 441,669 |
| Market cap | 57.091M |
| Beta (5Y monthly) | 1.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.23 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 35.25 |
ZacksBlueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Blueprint (BPMC) gains from better-than-expected first-quarter 2024 results, driven by robust Ayvakit sales growth. The company raises its revenue guidance for 2024.
ZacksZoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.
ZacksNovo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
Novo Nordisk (NVO) reports better-than-expected first-quarter results, beating both earnings and revenues, driven by strong sales of Diabetes and Obesity care products.
© 2024 Yahoo. All rights reserved.